The Influence of Breast Cancer Treatment on the Occurrence of Hot Flashes

Journal of Pain and Symptom Management

Volumn 37, Issue 4, 2009, Pages 687-697

  Savard, Marie Hélène ^a   Savard, Josée ^a   Quesnel, Catherine ^a   Ivers, Hans ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adjuvant treatment; breast cancer; chemotherapy; hormone therapy; hot flashes; longitudinal study; radiation therapy; risk factor; vasomotor symptom

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MORBIDITY; PARTIAL MASTECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; TREATMENT DURATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HORMONES; HOT FLASHES; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; QUALITY OF LIFE; RADIOTHERAPY; RISK FACTORS;

EID: 63249086283     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2008.04.010     Document Type: Article

References (38)

1. Carpenter J.S., Elam J., Ridner S., et al. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31 3 (2004) 591-598
2. Carpenter J.S., Johnson D., Wagner L., and Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 29 (2002) E16-25
3. Ganz P.A., Rowland J.H., Desmond K., Meyerowitz B.E., and Wyatt G.E. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 16 2 (1998) 501-514
4. Harris P.F., Remington P.L., Trentham-Dietz A., Allen C.I., and Newcomb P.A. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 23 (2002) 501-509
5. Couzi R.J., Helzlsouer K.J., and Fetting J.H. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13 (1995) 2737-2744
6. Carpenter J.S., Andrykowski M.A., Cordova M., et al. Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82 (1998) 1682-1691
7. Duffy L.S., Greenberg D.B., Younger J., and Ferraro M.G. Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients. Psychosomatics 40 (1999) 304-308
8. Janz N.K., Mujahid M., Chung L.K., et al. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health 16 9 (2007) 1348-1361
9. Mom C.H., Buijs C., Willemse P.H., Mourits M.J., and de Vries E.G. Hot flushes in breast cancer patients. Crit Rev Oncol Hematol 57 1 (2006) 63-77
10. Carpenter J.S. State of the science: hot flashes and cancer. Part 1: Definition, scope, impact, physiology, and measurement. Oncol Nurs Forum 32 5 (2005) 959-968
11. Savard J., Davidson J.R., Ivers H., et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27 (2004) 513-522
12. Cella D., and Fallowfield L.J. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 107 2 (2008) 167-180
13. Canney P.A., and Hatton M.Q. The prevalence of menopausal symptoms in patients treated for breast cancer. Clin Oncol 6 (1994) 297-299
14. Ganz P.A., Rowland J.H., Meyerowitz B.E., and Desmond K.A. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res 152 (1998) 396-411
15. Stein K.D., Jacobsen P.B., Hann D.M., Greenberg H., and Lyman G. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage 19 (2000) 436-445
16. Biglia N., Cozzarella M., Cacciari F., et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas 45 1 (2003) 29-38
17. Young-McCaughan S. Sexual functioning in women with breast cancer after treatment with adjuvant therapy. Cancer Nurs 19 4 (1996) 308-319
18. Gupta P., Sturdee D.W., Palin S.L., et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9 1 (2006) 49-58
19. Morales L., Neven P., Timmerman D., et al. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs 15 8 (2004) 753-760
20. Loprinzi C.L., Zahasky K.M., Sloan J.A., Novotny P.J., and Quella S.K. Tamoxifen-induced hot flashes. Clin Breast Cancer 1 (2000) 52-56
21. Gold E.B., Flatt S.W., Pierce J.P., et al. Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study. Menopause 13 3 (2006) 423-433
22. Quesnel C, Savard J, Ivers H. Chemotherapy impairs verbal fluency in breast cancer patients. Breast Cancer Res Treat, in press.
23. Sloan J.A., Loprinzi C.L., Novotny P.J., et al. Methodologic lessons learned from hot flash studies. J Clin Oncol 19 (2001) 4280-4290
24. Finck G., Barton D.L., Loprinzi C.L., Quella S.K., and Sloan J.A. Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage 16 (1998) 327-333
25. Hilditch J.R., Lewis J., Peter A., et al. A menopause-specific quality of life questionnaire: development and psychometrics properties. Maturitas 24 (1996) 161-175
26. Lewis J.E., Hilditch J.R., and Wong C.J. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 50 3 (2005) 209-221
27. Tabachnik B.G., and Fidell L.S. Using multivariate statistics. 4th ed. (2001), Harper Collins Publishers, New York
28. SAS Institute. SAS/Stat 9.1 user's guide Vol. 1 to 7 (2004), SAS Institute, Cary, NC
29. Hosmer D.W., and Lemeshow S. Applied logistic regression. 2nd ed. (2000), John Wiley and Sons, New York
30. Molina J.R., Barton D.L., and Loprinzi C.L. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf 28 5 (2005) 401-416
31. Holmberg L., and Anderson H. HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped. Lancet 363 9407 (2004) 453-455
32. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
33. Erlik Y., Meldrum D.R., and Judd H.L. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 59 (1982) 403-407
34. Nelson H.D., Vesco K.K., Haney E., et al. Nonhormonal therapies for menopausal hot flashes. JAMA 295 17 (2006) 2057-2071
35. Miller H.G., and Li R.M. Measuring hot flashes: summary of a National Institutes of Health workshop. Mayo Clin Proc 79 6 (2004) 777-781
36. Carpenter J.S., Monahan P.O., and Azzouz F. Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol Clin North Am 104 6 (2004) 1322-1326
37. Bordeleau L., Pritchard K., Goodwin P., and Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther 29 2 (2007) 230-241
38. Tremblay A., Sheeran L., and Aranda S.K. Psychoeducational interventions to alleviate hot flashes: a systematic review. Menopause 15 1 (2008) 193-202